Long a ‘Crown Jewel’ of Government, N.I.H. Is Now a Targetnews2024-12-02T01:11:12+00:00December 2nd, 2024|The New York Times|
Why Casey Left Substack, Elon Musk and Drugs, and an A.I. Antibiotic Discoverynews2024-01-12T10:02:26+00:00January 12th, 2024|The New York Times|
The Billionaires Spending a Fortune to Lure Scientists Away From Universitiesnews2024-01-12T10:00:42+00:00January 12th, 2024|The New York Times|
National Academies Members Demand Answers About Sacklers’ Donationsnews2023-04-28T16:36:40+00:00April 28th, 2023|The New York Times|
After Long Delay, Moderna Pays N.I.H. for Covid Vaccine Techniquenews2023-02-23T23:25:31+00:00February 23rd, 2023|The New York Times|
The End of Covid Vaccines at ‘Warp Speed’news2022-11-18T14:02:03+00:00November 18th, 2022|The New York Times|
Bill Gates: We Must Develop Drugs Much Faster in the Next Pandemicnews2022-04-15T20:51:28+00:00April 15th, 2022|The New York Times|
Moderna and U.S. at Odds Over Vaccine Patent Rightsnews2021-11-10T00:23:03+00:00November 10th, 2021|The New York Times|
Headache Research Advances Though Cures Are Elusivenews2021-07-23T09:00:14+00:00July 23rd, 2021|The New York Times|
How an Unproven Alzheimer’s Drug Got Approvednews2021-07-20T02:12:00+00:00July 20th, 2021|The New York Times|
